Asia-Pacific Opioid-induced Constipation Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 117 pages | ID: AE650A017A4EN
99Strategy

Abstracts

SNAPSHOT
The Asia-Pacific Opioid-induced Constipation market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Opioid-induced Constipation by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Solid
• Liquid

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• AstraZeneca
• Takeda Pharmaceutical
• Valeant Pharmaceuticals International
• Abbott
• Bayer
• Boehringer Ingelheim
• C.B. Fleet
• Cosmo Pharmaceuticals
• Daewoong
• Daiichi Sankyo
• GlaxoSmithKline
• Ironwood Pharmaceuticals
• Johnson & Johnson
• Merck
• Mundipharma
• Nektar Therapeutics
• Pfizer
• Progenics Pharmaceuticals
• Shionogi
• SLA Pharma
• Sucampo
• Synergy Pharmaceuticals
• Theravance

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Drugstore
• Hospital
• Others

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Opioid-induced Constipation Industry
  1.1.1 Overview
  1.1.2 Development of Opioid-induced Constipation
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 AstraZeneca (Company Profile, Products & Services, Sales Data etc.)
2.2 Takeda Pharmaceutical (Company Profile, Products & Services, Sales Data etc.)
2.3 Valeant Pharmaceuticals International (Company Profile, Products & Services, Sales Data etc.)
2.4 Abbott (Company Profile, Products & Services, Sales Data etc.)
2.5 Bayer (Company Profile, Products & Services, Sales Data etc.)
2.6 Boehringer Ingelheim (Company Profile, Products & Services, Sales Data etc.)
2.7 C.B. Fleet (Company Profile, Products & Services, Sales Data etc.)
2.8 Cosmo Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.9 Daewoong (Company Profile, Products & Services, Sales Data etc.)
2.10 Daiichi Sankyo (Company Profile, Products & Services, Sales Data etc.)
2.11 GlaxoSmithKline (Company Profile, Products & Services, Sales Data etc.)
2.12 Ironwood Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.13 Johnson & Johnson (Company Profile, Products & Services, Sales Data etc.)
2.14 Merck (Company Profile, Products & Services, Sales Data etc.)
2.15 Mundipharma (Company Profile, Products & Services, Sales Data etc.)
2.16 Nektar Therapeutics (Company Profile, Products & Services, Sales Data etc.)
2.17 Pfizer (Company Profile, Products & Services, Sales Data etc.)
2.18 Progenics Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.19 Shionogi (Company Profile, Products & Services, Sales Data etc.)
2.20 SLA Pharma (Company Profile, Products & Services, Sales Data etc.)
2.21 Sucampo (Company Profile, Products & Services, Sales Data etc.)
2.22 Synergy Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.23 Theravance (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 OPIOID-INDUCED CONSTIPATION MARKET BY TYPE

4.1 By Type
  4.1.1 Solid
  4.1.2 Liquid
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Drugstore
  5.1.2 Demand in Hospital
  5.1.3 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Segment of Opioid-induced Constipation
Table Asia-Pacific Opioid-induced Constipation Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Opioid-induced Constipation
Table Asia-Pacific Opioid-induced Constipation Market 2012-2023, by Application, in USD Million
Table AstraZeneca Overview List
Table Opioid-induced Constipation Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Overview List
Table Opioid-induced Constipation Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List
Table Opioid-induced Constipation Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Opioid-induced Constipation Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Opioid-induced Constipation Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Opioid-induced Constipation Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table C.B. Fleet Overview List
Table Opioid-induced Constipation Business Operation of C.B. Fleet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Overview List
Table Opioid-induced Constipation Business Operation of Daewoong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Opioid-induced Constipation Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Opioid-induced Constipation Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ironwood Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Ironwood Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Opioid-induced Constipation Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Opioid-induced Constipation Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma Overview List
Table Opioid-induced Constipation Business Operation of Mundipharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Opioid-induced Constipation Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Opioid-induced Constipation Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Progenics Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi Overview List
Table Opioid-induced Constipation Business Operation of Shionogi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SLA Pharma Overview List
Table Opioid-induced Constipation Business Operation of SLA Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sucampo Overview List
Table Opioid-induced Constipation Business Operation of Sucampo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Synergy Pharmaceuticals Overview List
Table Opioid-induced Constipation Business Operation of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Theravance Overview List
Table Opioid-induced Constipation Business Operation of Theravance (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Opioid-induced Constipation Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Opioid-induced Constipation Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Opioid-induced Constipation Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Opioid-induced Constipation Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Solid
Table Major Company List of Liquid
Table Asia-Pacific Opioid-induced Constipation Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Opioid-induced Constipation Market 2012-2017, by Type, in Volume
Table Asia-Pacific Opioid-induced Constipation Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Opioid-induced Constipation Market Forecast 2018-2023, by Type, in Volume
Table Opioid-induced Constipation Demand in Drugstore, 2012-2017, in USD Million
Table Opioid-induced Constipation Demand in Drugstore, 2012-2017, in Volume
Table Major Consumers in Drugstore
Table Opioid-induced Constipation Demand in Hospital, 2012-2017, in USD Million
Table Opioid-induced Constipation Demand in Hospital, 2012-2017, in Volume
Table Major Consumers in Hospital
Table Opioid-induced Constipation Demand in Others, 2012-2017, in USD Million
Table Opioid-induced Constipation Demand in Others, 2012-2017, in Volume
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Opioid-induced Constipation Demand Forecast 2018-2023, by Application, in USD Million
Table Opioid-induced Constipation Demand Forecast 2018-2023, by Application, in Volume
Table Opioid-induced Constipation Production 2012-2017, by Region, in USD Million
Table Opioid-induced Constipation Production 2012-2017, by Region, in Volume
Table Asia-Pacific Opioid-induced Constipation Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Opioid-induced Constipation Market Size 2012-2017, by Region, in Volume
Table China Opioid-induced Constipation Market Size 2012-2017, by Type, in USD Million
Table China Opioid-induced Constipation Market Size 2012-2017, by Type, in Volume
Table China Opioid-induced Constipation Market Size 2012-2017, by Application, in USD Million
Table China Opioid-induced Constipation Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Opioid-induced Constipation Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Opioid-induced Constipation Market Size 2012-2017, by Country, in Volume
Table Japan Opioid-induced Constipation Market Size 2012-2017, by Type, in USD Million
Table Japan Opioid-induced Constipation Market Size 2012-2017, by Type, in Volume
Table Japan Opioid-induced Constipation Market Size 2012-2017, by Application, in USD Million
Table Japan Opioid-induced Constipation Market Size 2012-2017, by Application, in Volume
Table India Opioid-induced Constipation Market Size 2012-2017, by Country, in USD Million
Table India Opioid-induced Constipation Market Size 2012-2017, by Country, in Volume
Table India Opioid-induced Constipation Market Size 2012-2017, by Type, in USD Million
Table India Opioid-induced Constipation Market Size 2012-2017, by Type, in Volume
Table India Opioid-induced Constipation Market Size 2012-2017, by Application, in USD Million
Table India Opioid-induced Constipation Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Opioid-induced Constipation Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Opioid-induced Constipation Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Opioid-induced Constipation Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Opioid-induced Constipation Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Opioid-induced Constipation Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Opioid-induced Constipation Market Size 2012-2017, by Application, in Volume
Table Oceania Opioid-induced Constipation Market Size 2012-2017, by Country, in USD Million
Table Oceania Opioid-induced Constipation Market Size 2012-2017, by Country, in Volume
Table Oceania Opioid-induced Constipation Market Size 2012-2017, by Type, in USD Million
Table Oceania Opioid-induced Constipation Market Size 2012-2017, by Type, in Volume
Table Oceania Opioid-induced Constipation Market Size 2012-2017, by Application, in USD Million
Table Oceania Opioid-induced Constipation Market Size 2012-2017, by Application, in Volume
Table Opioid-induced Constipation Market Forecast 2018-2023, by Region, in USD Million
Table Opioid-induced Constipation Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Opioid-induced Constipation

List Of Figures

LIST OF FIGURES

Figure Opioid-induced Constipation Industry Chain Structure
Figure Asia-Pacific Opioid-induced Constipation Market Size and Growth Rate 2012-2023
Figure China Opioid-induced Constipation Market, by Company, in 2018
Figure Japan & Korea Opioid-induced Constipation Market, by Company, in 2018
Figure India Opioid-induced Constipation Market, by Company, in 2018
Figure Southeast Asia Opioid-induced Constipation Market, by Company, in 2018
Figure Oceania Opioid-induced Constipation Market, by Company, in 2018
Figure Asia-Pacific Opioid-induced Constipation Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Opioid-induced Constipation Market Growth 2012-2017, by Type, in Volume
Figure China Opioid-induced Constipation Market Size and Growth 2012-2017, in USD Million
Figure China Opioid-induced Constipation Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Opioid-induced Constipation Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Opioid-induced Constipation Market Size and Growth 2012-2017, in Volume
Figure India Opioid-induced Constipation Market Size and Growth 2012-2017, in USD Million
Figure India Opioid-induced Constipation Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Opioid-induced Constipation Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Opioid-induced Constipation Market Size and Growth 2012-2017, in Volume
Figure Oceania Opioid-induced Constipation Market Size and Growth 2012-2017, in USD Million
Figure Oceania Opioid-induced Constipation Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview